- Home
- SFHG vs LGVN Comparison
SFHG vs LGVN Comparison
Compare SFHG & LGVN Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
Current Price
Company Overview
Basic Information| Metric | SFHG | LGVN |
|---|---|---|
| Founded | 1993 | 2014 |
| Country | Hong Kong | United States |
| Employees | N/A | N/A |
| Industry | Publishing | Medicinal Chemicals and Botanical Products |
| Sector | Consumer Discretionary | Health Care |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 11.6M | 12.7M |
| IPO Year | 2024 | 2021 |
Fundamental Metrics
Financial Performance| Metric | SFHG | LGVN |
|---|---|---|
| Price | $0.80 | $0.59 |
| Analyst Decision | | Strong Buy |
| Analyst Count | 0 | 2 |
| Target Price | N/A | ★ $6.50 |
| AVG Volume (30 Days) | 144.9K | ★ 373.2K |
| Earning Date | 10-30-2025 | 11-04-2025 |
| Dividend Yield | N/A | N/A |
| EPS Growth | N/A | N/A |
| EPS | ★ N/A | N/A |
| Revenue | ★ $19,577,200.00 | $1,437,000.00 |
| Revenue This Year | N/A | N/A |
| Revenue Next Year | N/A | N/A |
| P/E Ratio | N/A | N/A |
| Revenue Growth | ★ 3.56 | N/A |
| 52 Week Low | $0.32 | $0.49 |
| 52 Week High | $2.32 | $2.24 |
Technical Indicators
Market Signals| Indicator | SFHG | LGVN |
|---|---|---|
| Relative Strength Index (RSI) | 56.41 | 49.59 |
| Support Level | $0.70 | $0.49 |
| Resistance Level | $0.98 | $0.60 |
| Average True Range (ATR) | 0.09 | 0.03 |
| MACD | -0.02 | 0.01 |
| Stochastic Oscillator | 43.42 | 69.70 |
Price Performance
Historical ComparisonAbout SFHG Samfine Creation Holdings Group Limited Ordinary Share
Samfine Creation Holdings Group Ltd operates through its subsidiaries. It is an established one-stop printing service provider which principally provides printing services in Hong Kong and the PRC. It offers a wide range of printed products such as (i) book products, which mainly include children's books, educational books, art books, notebooks, diaries and journals; and (ii) novelty and packaging products, which mainly include handcraft products, book sets, pop-up books, stationery products, products with assembly parts and other specialized products, shopping bags and package boxes.
About LGVN Longeveron Inc.
Longeveron Inc is a clinical-stage biotechnology company developing regenerative medicines to address unmet medical needs for specific aging-related and life-threatening conditions. Its investigational product is Lomecel-B an stem cell formulation sourced from the bone marrow of young, healthy adult donors and has potential mechanisms of action that can promote tissue repair and healing. The company currently has three pipeline indications: Hypoplastic Left Heart Syndrome (HLHS), Alzheimer's disease (AD) and Aging-related Frailty.